Ledger.
Investor · New York, NY

Ryan Belanger-Saleh

Open Ryan in the network graph →
Filings
12
SEC Form D
Connections
36
co-filers
Capital
$5.6M
across filings
Active
Mar 2019
to May 2021

Most-connected co-filers (36)

Acuta Capital Partners, Llc · Belmont, CA6 sharedManfred Yu · Belmont, CA6 sharedAnupam Dalal · Pacific Palisades, CA6 sharedRavi Singh · Cambridge, MA6 sharedJeffrey Myers · New York, NY6 sharedZach Bratun-Glennon · Philadelphia, PA6 sharedSue L. Sobeck · Kalamazoo, MI6 sharedAcuta Capital Partners, Llc · Belmont, CA6 sharedAcuta Capital Partners, Llc · Belmont, CA6 sharedWilliam P. Corry · Vero Beach, FL4 sharedSaira K. Ramasastry · Raleigh, NC4 sharedAnthony Maida · Raleigh, NC4 sharedScott Zeilinger · New York, NY4 sharedChristopher D. Long · Mission Woods, KS4 sharedSandeep Laumas · Raleigh, NC4 sharedJay P. Madan · Raleigh, NC4 sharedArnar Agnarsson · Bozeman, MT4 sharedKevin Cavenaugh · Portland, OR4 sharedRoy K. Proujansky · Raleigh, NC4 sharedLorin K. Johnson · Raleigh, NC4 sharedRuan Van Vuuren · Grand Cayman, Cayman Islands4 sharedShinji Kim · SAN FRANCISCO, CA4 sharedCampbell Congdon · Grand Cayman, Cayman Islands4 sharedJohn Bykowski · Hayward, CA3 shared

Recent filings (12)

Gatsby Digital, Inc.May 2021 · 5 co-filers$5.0MGatsby Digital, Inc.Jun 2020 · 11 co-filers$750KAcuta Opportunity Fund, LPMar 2020 · 8 co-filersAcuta Opportunity Offshore Fund, Ltd.Mar 2020 · 11 co-filersAcuta Capital Offshore Fund, Ltd.Mar 2020 · 11 co-filersAcuta Capital Fund, LPMar 2020 · 8 co-filersINNOVATE BIOPHARMACEUTICALS, INC.Jan 2020 · 19 co-filers$2.8MINNOVATE BIOPHARMACEUTICALS, INC.May 2019 · 17 co-filers$8.7MINNOVATE BIOPHARMACEUTICALS, INC.Apr 2019 · 16 co-filers$9.7MAcuta Opportunity Fund, LPMar 2019 · 8 co-filersAcuta Capital Fund, LPMar 2019 · 8 co-filersINNOVATE BIOPHARMACEUTICALS, INC.Mar 2019 · 17 co-filers$5.5M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Ryan in the interactive graph →